Pharmacological management of migraine: current strategies and future directions
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Fulltext
Final published version, 835 KB, PDF document
Introduction: Migraine is a complex neurological disorder that affects a significant portion of the global population. As traditional pharmacological approaches often fall short in alleviating symptoms, the development of innovative therapies has garnered significant interest. This text aims to summarize the current pharmacological options for managing migraine and to explore the potential impact of novel therapies. Areas covered: We focused on conventional treatments, emerging therapies, and novel compounds in clinical development, including therapies targeting the trigeminovascular system, cannabis-based therapies, hormonal and metabolic therapies, and other options. English peer-reviewed articles were searched in PubMed, Scopus, and ClinicalTrials.gov electronic databases. Expert opinion: Several novel treatment options for migraine have become available in recent years. Emerging pharmacological therapies targeting the trigeminovascular system, cannabis-based therapies, hormonal and metabolic interventions, and other emerging treatment modalities, may prove to be valuable for the treatment of migraine. Further research, clinical trials, and substantiated evidence are necessary to validate the efficacy, safety, and long-term outcomes of these therapeutic options.
Original language | English |
---|---|
Journal | Expert Opinion on Pharmacotherapy |
Volume | 25 |
Issue number | 6 |
Pages (from-to) | 673-683 |
ISSN | 1465-6566 |
DOIs | |
Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:
© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
- CGRP, gepant, headache, pain, trigeminovascular system
Research areas
ID: 392580068